Quintiles Transitional Holdings Inc. (Q) Expected to Post Earnings of $1.05 Per Share
Analysts forecast that Quintiles Transitional Holdings Inc. (NYSE:Q) will post earnings per share of $1.05 for the current quarter, according to Zacks Investment Research. Eight analysts have made estimates for Quintiles Transitional Holdings’ earnings, with estimates ranging from $1.04 to $1.07. Quintiles Transitional Holdings reported earnings of $0.93 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 12.9%. The firm is expected to report its next earnings report on Wednesday, July 26th.
According to Zacks, analysts expect that Quintiles Transitional Holdings will report full year earnings of $4.53 per share for the current financial year, with EPS estimates ranging from $4.47 to $4.62. For the next financial year, analysts forecast that the business will post earnings of $5.20 per share, with EPS estimates ranging from $4.85 to $5.43. Zacks’ earnings per share averages are an average based on a survey of sell-side research analysts that that provide coverage for Quintiles Transitional Holdings.
Quintiles Transitional Holdings (NYSE:Q) last released its earnings results on Wednesday, May 3rd. The medical research company reported $1.01 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.95 by $0.06. The firm had revenue of $1.91 billion during the quarter, compared to analyst estimates of $1.91 billion. Quintiles Transitional Holdings had a return on equity of 18.03% and a net margin of 1.06%. Quintiles Transitional Holdings’s revenue was up 72.5% compared to the same quarter last year. During the same period last year, the business posted $0.89 earnings per share.
Several analysts recently issued reports on the company. Jefferies Group LLC reiterated a “hold” rating and issued a $81.00 price target (up from $78.00) on shares of Quintiles Transitional Holdings in a report on Friday, May 5th. Mizuho increased their price target on Quintiles Transitional Holdings from $90.00 to $93.00 and gave the company a “buy” rating in a report on Thursday, May 4th. Credit Suisse Group reiterated an “outperform” rating and issued a $96.00 price target (up from $94.00) on shares of Quintiles Transitional Holdings in a report on Tuesday, June 6th. Evercore ISI reiterated an “in-line” rating and issued a $88.50 price target (up from $84.00) on shares of Quintiles Transitional Holdings in a report on Thursday, May 4th. Finally, Zacks Investment Research downgraded Quintiles Transitional Holdings from a “hold” rating to a “sell” rating in a report on Wednesday, April 26th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and nine have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $84.28.
In other news, Director John G. Danhakl sold 761,143 shares of the stock in a transaction dated Tuesday, May 30th. The shares were sold at an average price of $84.01, for a total transaction of $63,943,623.43. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Jack M. Greenberg sold 6,092 shares of the stock in a transaction dated Wednesday, May 17th. The stock was sold at an average price of $82.50, for a total transaction of $502,590.00. Following the transaction, the director now directly owns 2,930 shares in the company, valued at approximately $241,725. The disclosure for this sale can be found here. Insiders have sold 8,758,400 shares of company stock worth $735,783,985 in the last ninety days. Corporate insiders own 6.40% of the company’s stock.
Several institutional investors have recently modified their holdings of Q. Metropolitan Life Insurance Co. NY boosted its position in shares of Quintiles Transitional Holdings by 80.8% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 8,522 shares of the medical research company’s stock valued at $648,000 after buying an additional 3,809 shares during the last quarter. Ellington Management Group LLC bought a new position in shares of Quintiles Transitional Holdings during the fourth quarter valued at approximately $274,000. Flinton Capital Management LLC bought a new position in shares of Quintiles Transitional Holdings during the fourth quarter valued at approximately $437,000. New York State Teachers Retirement System boosted its position in shares of Quintiles Transitional Holdings by 73.6% in the fourth quarter. New York State Teachers Retirement System now owns 12,500 shares of the medical research company’s stock valued at $951,000 after buying an additional 5,300 shares during the last quarter. Finally, Credit Agricole S A boosted its position in shares of Quintiles Transitional Holdings by 240.6% in the fourth quarter. Credit Agricole S A now owns 70,719 shares of the medical research company’s stock valued at $5,378,000 after buying an additional 49,958 shares during the last quarter. 92.54% of the stock is currently owned by institutional investors and hedge funds.
Quintiles Transitional Holdings (NYSE Q) opened at 90.88 on Friday. The stock has a market capitalization of $20.00 billion, a price-to-earnings ratio of 201.06 and a beta of 0.64. The company has a 50-day moving average price of $85.16 and a 200-day moving average price of $80.17. Quintiles Transitional Holdings has a 12-month low of $61.21 and a 12-month high of $91.81.
Quintiles Transitional Holdings Company Profile
Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.